OraSure Stock Price (NASDAQ:OSUR)

Add to My Stocks
$13.11 $0.09 (0.69%) OSUR stock closing price Apr 28, 2017 (Closing)
28 APR 2017
amigobulls logo
OSUR hand_up
OSUR vs S&P 500
Closing Price: Apr 28, 2017
$13.11 ( 0.73%)
S&P 500
2384.2 ( -0.19%)
52 Week Price Range
1 Year Return: 76.59%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Profit
PE Valuation
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

OraSure Snapshot Video

12 5 2

OSUR Stock Details

Prev Close* : $13.02
Market Cap:
Day Low: $13
52 Week Low: $5.57
Open: $13.05
Volume: 668301
Day High: $13.23
52 Week High: $13.30

Latest Stock Market News

Latest Articles

OraSure News - From Partners

OSUR Stockcharts

View OSUR PE ratio, PS ratio stocks charts and compare with peers.
OSUR Chart
Note: Compare OraSure stock price history with the index and industry peers.

OraSure Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

OraSure Returns

(return on equity)

OraSure Financial Ratios

Asset Turnover
Receivables Turnover

OSUR Industry Peers

Company Price Change (%)
Insys Therapeutics (INSY)11.250.13 (1.14%)
Quidel Corp (QDEL)24.170.02 (0.08%)
Chembio Diagnostics (CEMI)6.250.05 (0.81%)
Alere (ALR)49.170.07 (0.14%)
American Bio Medica (ABMC)0.130.02 (13.33%)
Thermo Fisher Scientific (TMO)165.331.37 (0.82%)
Trinity Biotech (TRIB)5.690.04 (0.71%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Hill-Rom (HRC)75.641.8 (2.44%)
Zimmer Biomet Holdings (ZBH)119.651.55 (1.31%)
Boston Scientific (BSX)26.380.2 (0.76%)
Stryker (SYK)136.371 (0.74%)
Trinity Biotech (TRIB)5.690.04 (0.71%)
OraSure (OSUR)13.110.09 (0.69%)
ICU Medical (ICUI)153.80.85 (0.56%)
Top gainers from Medical Products industry
* As of Apr 29, 2017
CompanyPriceChange (%)
Abaxis (ABAX)45.034.32 (8.75%)
TG Therapeutics (TGTX)11.050.9 (7.53%)
ResMed (RMD)67.994.86 (6.67%)
LeMaitre Vascular (LMAT)29.752.11 (6.62%)
Conatus Pharma (CNAT)8.360.41 (4.68%)
Enzymotec (ENZY)8.60.25 (2.82%)
SurModics (SRDX)22.850.65 (2.77%)
Top losers from Medical Products industry
* As of Apr 29, 2017

OraSure Technologies, Inc. Stock News - Partner Headlines

OraSure Financial Statements

income statement20162015201420132012
Net Sales Or Revenues128.19M119.71M106.46M98.94M87.82M
Net Income19.72M8.16M-4.61M-11.19M-15.11M
Total Operating Expense67.75M72.23M71.41M70.74M71.83M
view OraSure Technologies, Inc. income statement
balance sheet20162015201420132012
Total Assets207.93M189.32M189.63M184.24M191.72M
Total Liabilities22.08M29.88M30.93M23.09M21.41M
Shareholders Equity185.85M159.43M158.7M161.14M170.31M
view OraSure Technologies, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-8.22M-4.63M0.09M8.22M-1.32M
Net Cash From (Used By) Operating Activities22.76M15.77M7.52M8.38M-5.37M
Increase (Decrease) In Prop Plant And Equipment-4.35M-3.74M-3M-2.46M-2.01M
view OraSure Technologies, Inc. cashflow statement

OraSure Stock Message Board

As of last trading day, OraSure stock price was 13.11. The total market value as denoted by 760.15M for OraSure, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing OraSure stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that OraSure is worth a lot, it will most likely be reflected in an inflated OraSure stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 668301 shares were traded with a closing stock price of 13.11 as of 28 Apr, 2017, as can be seen from OraSure stock quote. One can view OraSure stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. OraSure stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.